Answers are grounded in this paper and cite their sources.
Six new [Cu(XQ) 2 ] complexes (HXQ are derivatives of 8-hydroxyquinoline bearing methyl or aldehyde functional groups) were prepared with an emphasis on their preparation in a crystalline state using liquid-liquid, vapour-liquid and horizontal diffusions. Their composition is [Cu(dClMeQ) 2 ] ( 1 ), [Cu(dBrMeQ) 2 ] n ( 2 ), [Cu(dIMeQ) 2 ] n ( 3 ), [Cu(AQ) 2 ] n ( 4 ), [Cu(dBrAQ) 2 ] n ( 5 ) and [Cu(dIAQ) 2 ] n ( 6 ) (HdClMeQ is 5,7-dichloro-8-hydroxyquinaldine, HdBrMeQ is 5,7-dibromo-8-hydroxyquinaldine, HdIMeQ is 5,7-diiodo-8-hydroxyquinaldine, HAQ is 8-hydroxyquinoline-2-carbaldehyde, HdBrAQ is 5,7-dibromo-8-hydroxyquinoline-2-carbaldehyde and HdIAQ is 5,7-diiodo-8-hydroxyquinoline-2-carbaldehyde). The complexes were characterised by infrared and UV-vis spectroscopy, elemental analysis and X-ray structural analysis (except 1 ). Deprotonated XQ ligands bind as bidentate chelates to the copper atom via the oxygen and nitrogen atoms of 8-hydroxyquinoline rings in all five compounds in the equatorial plane of an elongated tetragonal bipyramid. Oxygen ( 2c , 4c - 6c ) or iodine atoms ( 3c ) of neighbouring [Cu(XQ) 2 ] molecules occupy axial positions and polymeric structures are thus formed, which are stabilised by hydrogen bonds and π-π interactions. This is a probable reason for their insolubility in a wide range of solvents. Crystal packing was further investigated by Hirshfeld surface analysis.
No takes yet. Share an insight, caveat, or question.
Kepeňová et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: